Inventor
Dongbing Cui
Inventor
Shanghai, CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
C12NMicroorganisms or enzymes20%
PatentTitleYear
10,815,304PD-L1 antibody, antigen-binding fragment thereof and medical application thereof202010,793,643PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof202010,543,284Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof202010,449,250Anti-sclerostin antibody, antigen binding fragment and medical use thereof2019Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2019–2020Patents assigned to JIANGSU HENGRUI MEDICINE CO (4)· patent assignee history
2019–2020Patents assigned to Shanghai hengrui pharmaceutical co ltd (4)· patent assignee history
2019–2020Based in Shanghai, CN· patent location history
2020Patents assigned to SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JIANGSU HENGRUI MEDICINE CO | 4 | 2019–2020 |
| Shanghai hengrui pharmaceutical co ltd | 4 | 2019–2020 |
| SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD | 2 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Shanghai, CN | 4 | 2019–2020 |